191 related articles for article (PubMed ID: 14702535)
1. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity?
Desai NM; Goss JA; Deng S; Wolf BA; Markmann E; Palanjian M; Shock AP; Feliciano S; Brunicardi FC; Barker CF; Naji A; Markmann JF
Transplantation; 2003 Dec; 76(11):1623-5. PubMed ID: 14702535
[TBL] [Abstract][Full Text] [Related]
2. Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model.
Hirshberg B; Preston EH; Xu H; Tal MG; Neeman Z; Bunnell D; Soleimanpour S; Hale DA; Kirk AD; Harlan DM
Transplantation; 2003 Jul; 76(1):55-60. PubMed ID: 12865786
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression for pancreatic islet transplantation.
Berney T; Buhler LH; Majno P; Mentha G; Morel P
Transplant Proc; 2004 Mar; 36(2 Suppl):362S-366S. PubMed ID: 15041369
[TBL] [Abstract][Full Text] [Related]
4. The portal immunosuppressive storm: relevance to islet transplantation?
Shapiro AM; Gallant HL; Hao EG; Lakey JR; McCready T; Rajotte RV; Yatscoff RW; Kneteman NM
Ther Drug Monit; 2005 Feb; 27(1):35-7. PubMed ID: 15665744
[TBL] [Abstract][Full Text] [Related]
5. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
6. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression.
Hirshberg B; Mog S; Patterson N; Leconte J; Harlan DM
J Clin Endocrinol Metab; 2002 Dec; 87(12):5424-9. PubMed ID: 12466330
[TBL] [Abstract][Full Text] [Related]
7. Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations.
Berney T; Bucher P; Mathe Z; Andres A; Bosco D; Mage R; Toso C; Oberholzer J; Becker C; Philippe J; Bühler L; Morel P
Transplant Proc; 2004 May; 36(4):1121-2. PubMed ID: 15194390
[TBL] [Abstract][Full Text] [Related]
8. Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.
Barshes NR; Lee T; Goodpasture S; Brunicardi FC; Alejandro R; Ricordi C; Soltes G; Barth M; Hamilton D; Goss JA
Transplant Proc; 2004 May; 36(4):1127-9. PubMed ID: 15194393
[TBL] [Abstract][Full Text] [Related]
9. Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device.
Marzorati S; Bocca N; Molano RD; Hogan AR; Doni M; Cobianchi L; Inverardi L; Ricordi C; Pileggi A
Transplant Proc; 2009; 41(1):352-3. PubMed ID: 19249555
[TBL] [Abstract][Full Text] [Related]
10. Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation.
Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
Transplant Proc; 2005 Mar; 37(2):1326-7. PubMed ID: 15848711
[TBL] [Abstract][Full Text] [Related]
11. Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.
Gillard P; Ling Z; Mathieu C; Crenier L; Lannoo M; Maes B; Roep B; Gorus F; Pipeleers D; Keymeulen B
Transplantation; 2008 Jan; 85(2):256-63. PubMed ID: 18212631
[TBL] [Abstract][Full Text] [Related]
12. Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen.
Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
Transpl Int; 2005 Nov; 18(11):1226-30. PubMed ID: 16221151
[TBL] [Abstract][Full Text] [Related]
13. Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.
Toso C; Morel P; Bucher P; Mathe Z; Demuylder-Mischler S; Bosco D; Berney T; Oberholzer J; Shapiro J; Oberholzer J; Philippe J
Transplantation; 2003 Oct; 76(7):1133-4. PubMed ID: 14557767
[No Abstract] [Full Text] [Related]
14. Successful islet after kidney transplantations in a distance over 1000 kilometres: Preliminary results of the Budapest-Geneva collaboration.
Langer RM; Máthé Z; Doros A; Máthé ZS; Weszelits V; Filó A; Bucher P; Morel P; Berney T; Járay J
Transplant Proc; 2004 Dec; 36(10):3113-5. PubMed ID: 15686708
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.
Oellerich M; Armstrong VW; Streit F; Weber L; Tönshoff B
Clin Biochem; 2004 Jun; 37(6):424-8. PubMed ID: 15183289
[TBL] [Abstract][Full Text] [Related]
16. Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol.
Toso C; Baertschiger R; Morel P; Bosco D; Armanet M; Wojtusciszyn A; Badet L; Philippe J; Becker CD; Hadaya K; Majno P; Bühler L; Berney T;
Am J Transplant; 2006 May; 6(5 Pt 1):1049-58. PubMed ID: 16611343
[TBL] [Abstract][Full Text] [Related]
17. Insulin independence achieved using the transmesenteric approach to the portal vein for islet transplantation.
Osama Gaber A; Chamsuddin A; Fraga D; Fisher J; Lo A
Transplantation; 2004 Jan; 77(2):309-11. PubMed ID: 14742999
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus-atorvastatin drug interaction in the pancreatic islet transplant recipient.
Barshes NR; Goodpastor SE; Goss JA
Transplantation; 2003 Dec; 76(11):1649-50. PubMed ID: 14702546
[No Abstract] [Full Text] [Related]
19. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM
Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
